<VariationArchive VariationID="1691448" VariationName="NM_001080.3(ALDH5A1):c.728_736del (p.Leu243_Ser245del)" VariationType="Deletion" Accession="VCV001691448" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-23" DateCreated="2022-06-16" MostRecentSubmission="2023-01-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1683926" VariationID="1691448">
      <GeneList>
        <Gene Symbol="ALDH5A1" FullName="aldehyde dehydrogenase 5 family member A1" GeneID="7915" HGNC_ID="HGNC:408" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6p22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="24494969" stop="24537207" display_start="24494969" display_stop="24537207" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="24495196" stop="24537434" display_start="24495196" display_stop="24537434" Strand="+" />
          </Location>
          <OMIM>610045</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001080.3(ALDH5A1):c.728_736del (p.Leu243_Ser245del)</Name>
      <CanonicalSPDI>NC_000006.12:24515166:CTTGCAAGCC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6p22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="24515167" stop="24515175" display_start="24515167" display_stop="24515175" variantLength="9" positionVCF="24515166" referenceAlleleVCF="GCTTGCAAGC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="24515395" stop="24515403" display_start="24515395" display_stop="24515403" variantLength="9" positionVCF="24515394" referenceAlleleVCF="GCTTGCAAGC" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.24515396_24515404del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.24515396_24515404del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.24515168_24515176del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.24515168_24515176del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008161.1" sequenceAccession="NG_008161" sequenceVersion="1" change="g.25200_25208del">
            <Expression>NG_008161.1:g.25200_25208del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001080.3" sequenceAccession="NM_001080" sequenceVersion="3" change="c.728_736del" MANESelect="true">
            <Expression>NM_001080.3:c.728_736del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001071.1" sequenceAccession="NP_001071" sequenceVersion="1" change="p.Leu243_Ser245del">
            <Expression>NP_001071.1:p.Leu243_Ser245del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_170740.1" sequenceAccession="NM_170740" sequenceVersion="1" change="c.767_775del">
            <Expression>NM_170740.1:c.767_775del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_733936.1" sequenceAccession="NP_733936" sequenceVersion="1" change="p.Leu256_Ser258del">
            <Expression>NP_733936.1:p.Leu256_Ser258del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368954.1" sequenceAccession="NM_001368954" sequenceVersion="1" change="c.727-5233_727-5225del">
            <Expression>NM_001368954.1:c.727-5233_727-5225del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001080.3" sequenceAccession="NM_001080" sequenceVersion="3" change="c.727_735del" MANESelect="true">
            <Expression>NM_001080.3:c.727_735del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2127385829" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001080.3(ALDH5A1):c.728_736del (p.Leu243_Ser245del) AND Succinate-semialdehyde dehydrogenase deficiency" Accession="RCV002254536" Version="5">
        <ClassifiedConditionList TraitSetID="369">
          <ClassifiedCondition DB="MedGen" ID="C0268631">Succinate-semialdehyde dehydrogenase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-03-08" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-03-08" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-06-16" MostRecentSubmission="2023-01-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="DOI">10.1080/09513590.2020.1744555</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32223457</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="369" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4471" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">4-hydroxybutyric aciduria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gamma-hydroxybutyricaciduria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Succinate-semialdehyde dehydrogenase deficiency</ElementValue>
                <XRef ID="Succinic+semialdehyde+dehydrogenase+deficiency/6917" DB="Genetic Alliance" />
                <XRef ID="49748000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SSADHD</ElementValue>
                <XRef Type="MIM" ID="271980" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Succinic semialdehyde dehydrogenase (SSADH) deficiency is characterized by infantile-onset hypotonia, developmental delay, cognitive impairment, expressive language deficit, and mild ataxia. Epilepsy is present in about half of affected individuals and is more common in adults. Hyperkinetic behavior, aggression, self-injurious behaviors, hallucinations, and sleep disturbances have been reported in nearly half of all affected individuals, more commonly in those who are older. Basal ganglia signs including choreoathetosis, dystonia, and myoclonus have been reported in a few individuals with earlier-onset, more severe disease. Involvement beyond the central nervous system has not been described. Individuals with SSADH deficiency typically have 4-hydroxybutyric aciduria present on urine organic acid analysis. Head MRI reveals T2 hyperintensities in multiple regions, involving the globus pallidi, cerebellar dentate nuclei, subthalamic nuclei, subcortical white matter, and brain stem, as well as cerebral and sometimes cerebellar atrophy. EEG findings include background slowing and spike discharges that are usually generalized.</Attribute>
                <XRef ID="NBK1195" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7695" />
                <XRef ID="7695" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301374</ID>
                <ID Source="BookShelf">NBK1195</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23519317</ID>
              </Citation>
              <XRef ID="22" DB="Orphanet" />
              <XRef ID="C0268631" DB="MedGen" />
              <XRef ID="MONDO:0010083" DB="MONDO" />
              <XRef Type="MIM" ID="271980" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5505099" SubmissionDate="2023-01-03" DateLastUpdated="2023-01-15" DateCreated="2023-01-15">
        <ClinVarSubmissionID localKey="NM_001080.3:c.728_736del|OMIM:271980" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002819954" DateUpdated="2023-01-15" DateCreated="2023-01-15" Type="SCV" Version="1" SubmitterName="Elsea Laboratory, Baylor College of Medicine" OrgID="242449" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32223457</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Martin et al. (J Child Neurol. 2021)</Attribute>
          <Citation>
            <ID Source="PubMed">34882073</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALDH5A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001080.3:c.728_736del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="271980" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507831</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4949067" SubmissionDate="2022-06-10" DateLastUpdated="2022-06-16" DateCreated="2022-06-16">
        <ClinVarSubmissionID localKey="SUB11566734" submittedAssembly="GRCh37" title="SUB11566734" />
        <ClinVarAccession Accession="SCV002522665" DateUpdated="2022-06-16" DateCreated="2022-06-16" Type="SCV" Version="1" SubmitterName="Department of Genetics and Endocrinology, Guangzhou Women and Childrenâ€™s Medical Center" OrgID="507487" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="DOI">10.1080/09513590.2020.1744555</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0025356" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001252" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Increased urinary excretion of GHB</ElementValue>
                </Name>
              </Trait>
            </TraitSet>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>not applicable</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not applicable</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>in vitro</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="MethodResult">We generated two homozygous ALDH5A1-mutated cell lines using CRISPR/Cas9 editing in a healthy human induced pluripotent stem cell (hiPSC) line, namely NM_001080.3: c.727_735del (p.L243_S245del) and NM_001080.3: c.730_738del (p.A244_Q246del). Further experiments suggested that the two mutations could affect the splicing of ALDH5A1 gene, and GABA products in mutant cell lines were accumulated.</Attribute>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALDH5A1">
              <Name>aldehyde dehydrogenase 5 family member A1</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001080.3:c.727_735del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="271980" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11566734</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4949067" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001252" MappingRef="HP">
        <MedGen CUI="C0026827" Name="Hypotonia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4949067" TraitType="Finding" MappingType="Name" MappingValue="Increased urinary excretion of GHB" MappingRef="Preferred">
        <MedGen CUI="None" Name="Increased urinary excretion of GHB" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4949067" TraitType="Finding" MappingType="XRef" MappingValue="HP:0025356" MappingRef="HP">
        <MedGen CUI="C0557874" Name="Global developmental delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4949067" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4949067" TraitType="Disease" MappingType="XRef" MappingValue="271980" MappingRef="OMIM">
        <MedGen CUI="C0268631" Name="Succinate-semialdehyde dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5505099" TraitType="Disease" MappingType="XRef" MappingValue="271980" MappingRef="OMIM">
        <MedGen CUI="C0268631" Name="Succinate-semialdehyde dehydrogenase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

